Applicability of the DAPT Study in contemporary clinical practice



The evidence on the optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) continues to evolve. Previous randomized trials of longer DAPT duration beyond 1 year have found that longer DAPT duration leads to fewer ischemic events at the expense of greater bleeding events

Copyright © 2020 Terumo India Private limited

X
Important information regarding

By using this website, you consent to the use of cookies in accordance with our